Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Abdun-Nabi Daniel, Director. Officer active across 1 company, notably Aptevo Therapeutics Inc.. In total, 6 reports have been recorded. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Daniel Abdun-Nabi is a Board Member at Aptevo Therapeutics Inc. He contributes to the governance of the company by participating in strategic decisions and bringing his expertise in the biotechnology field. His role is essential in supporting Aptevo's mission in developing innovative treatments.